MeiraGTx Holdings plc announced an agreement with Oberland Capital Management LLC for an investment of up to $400 million. This funding package includes up to $375 million in non-dilutive capital through capped royalty payments on certain products and up to $25 million in equity. The capital will support the potential commercialization of the company's late-stage programs for X-linked retinitis pigmentosa (XLRP) and radiation-induced xerostomia.
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
